OGN:NYSE
Organon & Co
US$13.90
arrow_downward
-0.07%(-0.010) 1D
ኖቬም 20, 3:10:02 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
US$13.89
High
US$13.91
Low
US$13.89
Mkt. cap
3.65 ቢ
Avg. vol.
2.72 ሚ
Volume
1.01 ሚ
Dividend
0.58%
Quarterly dividend
US$0.02
Ex-dividend date
14 ኦገስ 2026
P/E ratio
18.08
52-wk high
US$13.94
52-wk low
US$5.69
EPS
US$0.77
Beta
1.53
Shares outstanding
262.62 ሚ
No. of employees
10 ሺ
Open
US$13.89
High
US$13.91
Low
US$13.89
Mkt. cap
3.65 ቢ
Avg. vol.
2.72 ሚ
Volume
1.01 ሚ
Dividend
0.58%
Quarterly dividend
US$0.02
Ex-dividend date
14 ኦገስ 2026
P/E ratio
18.08
52-wk high
US$13.94
52-wk low
US$5.69
EPS
US$0.77
Beta
1.53
Shares outstanding
262.62 ሚ
No. of employees
10 ሺ
News stories
From web sources and news partners
Seeking Alpha
·
ከ1 ቀን በፊት
Organon: Deal Almost Done, Spread Almost Gone (Sell) (NYSE:OGN)
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 ሺ
Founded1923
HeadquartersJersey City, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com